Randomized trial of reduced-nicotine standards for cigarettes

New England Journal of Medicine

Volumn 373, Issue 14, 2015, Pages 1340-1349

  Donny, Eric C ^a   Denlinger, Rachel L ^a   Tidey, Jennifer W ^c   Koopmeiners, Joseph S ^d,g   Benowitz, Neal L ⁱ   Vandrey, Ryan G ^j   Al'Absi, Mustafa ^h   Carmella, Steven G ^g   Cinciripini, Paul M ^l   Dermody, Sarah S ^a   Drobes, David J ^m   Hecht, Stephen S ^g   Jensen, Joni ^g   Lane, Tonya ^a   Le, Chap T ^d,g   McClernon, F Joseph ⁿ   Montoya, Ivan D ^k   Murphy, Sharon E ^e,g   Robinson, Jason D ^l   Stitzer, Maxine L ^j   Strasser, Andrew A ^o   Tindle, Hilary ^b   Hatsukami, Dorothy K ^f,g   more..

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

^d University School of Public Health   (United States)

^e Departments of Psychiatry ^*  (United States)

^f The Department of Radiology   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^l UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^m H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

ⁿ DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; CARBON MONOXIDE; NICOTINE; BIOLOGICAL MARKER; CREATININE; TAR;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MULTICENTER STUDY; NICOTINE CONTENT; OUTCOME ASSESSMENT; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; SMOKING REGULATION; STANDARD; TOBACCO; TOBACCO DEPENDENCE; TOTAL PUFF VOLUME; URINE LEVEL; WITHDRAWAL SYNDROME; ANALYSIS; CHEMISTRY; CLINICAL TRIAL; EXPOSURE; FOOD AND DRUG ADMINISTRATION; STANDARDS; STATISTICAL MODEL; TOBACCO USE DISORDER; UNITED STATES; URINE;

BIOLOGICAL MARKERS; CREATININE; DOUBLE-BLIND METHOD; HUMANS; INHALATION EXPOSURE; LINEAR MODELS; NICOTINE; SUBSTANCE WITHDRAWAL SYNDROME; TARS; TOBACCO; TOBACCO PRODUCTS; TOBACCO USE DISORDER; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84942936771     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsa1502403     Document Type: Article

References (34)

1. Benowitz NL, Henningfield JE. Establishing a nicotine threshold for addiction: The implications for tobacco regulation. N Engl J Med 1994; 331: 123-5.
2. Henningfield JE, Benowitz NL, Slade J, Houston TP, Davis RM, Deitchman SD. Reducing the addictiveness of cigarettes. Tob Control 1998; 7: 281-93.
3. FDA v. Brown & Williamson Tobacco Corp. 529 U.S. 120 (2000).
4. Institute of Medicine. Ending the tobacco problem: A blueprint for the nation. Washington, DC: National Academies Press, 2007.
5. WHO Study Group on Tobacco Product Regulation. Report on the scientific basis of tobacco product regulation: Third report of a WHO study group. Geneva: World Health Organization, 2009.
6. The health consequences of smoking - 50 years of progress: A report of the Surgeon General: executive summary. Washington, DC: Department of Health and Human Services, 2014 (http://www.surgeongeneral.gov/library/reports/50-years-of-progress/exec-summary.pdf).
7. Family Smoking Prevention and Tobacco Control Act (H.R. 1256).
8. WHO Framework Convention on tobacco Control. Geneva: World Health Organization, 2003.
9. Donny EC, Houtsmuller E, Stitzer ML. Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction 2007; 102: 324-34.
10. Benowitz NL, Hall SM, Stewart S, Wilson M, Dempsey D, Jacob P III. Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer Epidemiol Biomarkers Prev 2007; 16: 2479-85.
11. Benowitz NL, Dains KM, Dempsey D, Herrera B, Yu L, Jacob P III. Urine nicotine metabolite concentrations in relation to plasma cotinine during low-level nicotine exposure. Nicotine Tob Res 2009; 11: 954-60.
12. Benowitz NL, Dains KM, Hall SM, et al. Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes. Cancer Epidemiol Biomarkers Prev 2012; 21: 761-9.
13. Hatsukami DK, Hertsgaard LA, Vogel RI, et al. Reduced nicotine content cigarettes and nicotine patch. Cancer Epidemiol Biomarkers Prev 2013; 22: 1015-24.
14. Hatsukami DK, Kotlyar M, Hertsgaard LA, et al. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction 2010; 105: 343-55.
15. Kozlowski LT, O'Connor RJ. Cigarette filter ventilation is a defective design because of misleading taste, bigger puffs, and blocked vents. Tob Control 2002; 11: Suppl 1: I40-I50.
16. Benowitz NL, Henningfield JE. Reducing the nicotine content to make cigarettes less addictive. Tob Control 2013; 22: Suppl 1: i14-i17.
17. Macqueen DA, Heckman BW, Blank MD, Janse Van Rensburg K, Evans DE, Drobes DJ. Transient compensatory smoking in response to placebo cigarettes. Psychopharmacology (Berl) 2012; 223: 47-54.
18. Hatsukami DK, Donny EC, Koopmeiners JS, Benowitz NL. Compensatory smoking from gradual and immediate reduction in cigarette nicotine content. Cancer Epidemiol Biomarkers Prev 2015; 24: 472-6.
19. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: A revision of the Fagerstr.m Tolerance Questionnaire. Br J Addict 1991; 86: 1119-27.
20. Smith SS, Piper ME, Bolt DM, et al. Development of the Brief Wisconsin Inventory of Smoking Dependence Motives. Nicotine Tob Res 2010; 12: 489-99.
21. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 1986; 43: 289-94.
22. Toll BA, O'Malley SS, McKee SA, Salovey P, Krishnan-Sarin S. Confirmatory factor analysis of the Minnesota Nicotine Withdrawal Scale. Psychol Addict Behav 2007; 21: 216-25.
23. Radloff LS. The CES-D scale: A selfreport depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
24. Cox LS, Tiffany ST, Christen AG. Evaluation of the Brief Questionnaire of Smoking Urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res 2001; 3: 7-16.
25. Scherer G, Engl J, Urban M, Gilch G, Janket D, Riedel K. Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regul Toxicol Pharmacol 2007; 47: 171-83.
26. Hukkanen J, Jacob P III, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005; 57: 79-115.
27. Murphy SE, Wickham KM, Lindgren BR, Spector LG, Joseph A. Cotinine and trans 3'-hydroxycotinine in dried blood spots as biomarkers of tobacco exposure and nicotine metabolism. J Expo Sci Environ Epidemiol 2013; 23: 513-8.
28. Murphy SE, Park SS, Thompson EF, et al. Nicotine N-glucuronidation relative to N-oxidation and C-oxidation and UGT2B10 genotype in five ethnic/racial groups. Carcinogenesis 2014; 35: 2526-33.
29. Carmella SG, Ming X, Olvera N, Brookmeyer C, Yoder A, Hecht SS. High throughput liquid and gas chromatography- tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers. Chem Res Toxicol 2013; 26: 1209-17.
30. Tengs TO, Ahmad S, Savage JM, Moore R, Gage E. The AMA proposal to mandate nicotine reduction in cigarettes: A simulation of the population health impacts. Prev Med 2005; 40: 170-80.
31. Dermody SS, Donny EC, Hertsgaard LA, Hatsukami DK. Greater reductions in nicotine exposure while smoking very low nicotine content cigarettes predict smoking cessation. Tob Control 2014 September 5 (Epub ahead of print).
32. Jha P, Chaloupka FJ. Curbing the epidemic: governments and the economics of tobacco control. Washington, DC: World Bank, 1999.
33. Thuerauf N, Kaegler M, Dietz R, Barocka A, Kobal G. Dose-dependent stereoselective activation of the trigeminal sensory system by nicotine in man. Psychopharmacology (Berl) 1999; 142: 236-43.
34. Donny EC, Hatsukami DK, Benowitz NL, Sved AF, Tidey JW, Cassidy RN. Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation. Prev Med 2014; 68: 17-22.